Skip to main content
Log in

Intranasal mometasone unlikely to be worth it for OME in the UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Intranasal mometasone unlikely to be worth it for OME in the UK. Pharmacoecon. Outcomes News 603, 2 (2010). https://doi.org/10.2165/00151234-201006030-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-201006030-00003

Keywords

Navigation